$0.021
-0.010 (-46.75%)收盘时
OCEA 同业对比
In the context of the broader market, OCEA competes directly with industry leaders such as INDP and SNGX. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, OCEA's gross margin of N/A stands against INDP's N/A and SNGX's N/A. Such benchmarking helps identify whether Ocean Biomedical Inc is trading at a premium or discount relative to its financial performance.
Financials
FY2022Q1
0.00
Total Revenue
FY2024Q4
YoY:
-365.61%
-1.75M
Operating Profit
FY2024Q4
YoY:
-101.68%
283.00K
Net Income after Tax
FY2024Q4
YoY:
-101.61%
0.01
EPS - Diluted
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。